Your browser doesn't support javascript.
loading
Assessment of Antihistamines and Corticosteroids as Premedication in Rapid Drug Desensitization to Paclitaxel: Outcomes in 155 Procedures.
Lopez-Gonzalez, Paula; Madrigal-Burgaleta, Ricardo; Carpio-Escalona, Laura Victoria; Bernal-Rubio, Lorena; Guerra, Eva; Berges-Gimeno, Maria Pilar; Alvarez-Cuesta, Emilio.
Afiliación
  • Lopez-Gonzalez P; Allergy Division, Ramon y Cajal University Hospital, Madrid, Spain.
  • Madrigal-Burgaleta R; Allergy Division, Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: ricardo.madrigal.md.phd@gmail.com.
  • Carpio-Escalona LV; Allergy Division, Ramon y Cajal University Hospital, Madrid, Spain.
  • Bernal-Rubio L; Allergy Division, Ramon y Cajal University Hospital, Madrid, Spain.
  • Guerra E; Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain.
  • Berges-Gimeno MP; Allergy Division, Ramon y Cajal University Hospital, Madrid, Spain.
  • Alvarez-Cuesta E; Allergy Division, Ramon y Cajal University Hospital, Madrid, Spain.
J Allergy Clin Immunol Pract ; 6(4): 1356-1362, 2018.
Article en En | MEDLINE | ID: mdl-29248386
BACKGROUND: In early clinical trials, infusion reactions during the administration of taxanes were managed using systematic premedication with antihistamines and corticosteroids before standard infusions. Consequently, these premedications are also administered before rapid drug desensitization (RDD) with taxanes. However, their role in RDD has not been studied. OBJECTIVE: To assess the need for premedication with antihistamines and corticosteroids to prevent hypersensitivity reactions in RDD to paclitaxel. METHODS: Over a 4-year period, we selected patients with confirmed hypersensitivity to paclitaxel (positive skin testing and/or drug provocation testing results) who had received paclitaxel through RDD. These patients were assigned to 2 prospective noninception cohorts: one cohort premedicated with antihistamine and corticosteroids and another cohort that was not. RESULTS: We assessed 66 paclitaxel-reactive patients, of whom 22 met the inclusion criteria. A total of 155 RDDs to paclitaxel were performed. There were no significant differences in tolerance to RDD between the cohorts. CONCLUSIONS: Administering systematic premedication with corticosteroids and antihistamines had no significant effect on the effectiveness or safety of RDD in patients with confirmed hypersensitivity to paclitaxel in the study population. Moreover, these premedications can mask early signs of hypersensitivity and delay treatment. We believe that systematic premedication with these drugs for patients undergoing RDD should be carefully and individually assessed if their only purpose is to prevent breakthrough reactions during RDD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Premedicación / Desensibilización Inmunológica / Paclitaxel / Corticoesteroides / Hipersensibilidad a las Drogas / Antagonistas de los Receptores Histamínicos / Antineoplásicos Fitogénicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2018 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Premedicación / Desensibilización Inmunológica / Paclitaxel / Corticoesteroides / Hipersensibilidad a las Drogas / Antagonistas de los Receptores Histamínicos / Antineoplásicos Fitogénicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2018 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos